TRANS-4-(4-VINYL-CYCLOHEXYL)-BENZONITRILE, 97.0%, 5g

tert-Butyl 4-bromo-2,6-difluorobenzoate, 97.0%, 100g

3-METHYL-2-OXOVALERIC, 95%, 100mg

3-Bromoisoxazole-5-carboxylic acid, 97.0%, 1g

Methyl benzo[d][1,3]dioxole-4-carboxylate, 95.0%, 100mg

6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid, 95.0%, 1g

6-Bromo-2-methylimidazo[1,2-a]pyrazine, 95.0%, 5g

Methyl 3-Aminocrotonate>98.0%(T)25g

MRS Agar, 5 kg

(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride, 97%, 10g

2-BROMO-4-FLUORO-5-METHOXYBENZALDEHYDE, 95.0%, 100mg

GC capillary column ROTI®Cap-5 HT, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

(1-cyclohexylethyl)amine hydrochloride, 95.0%, 250mg